CN1596943A - Leech capsule - Google Patents
Leech capsule Download PDFInfo
- Publication number
- CN1596943A CN1596943A CNA2004100245359A CN200410024535A CN1596943A CN 1596943 A CN1596943 A CN 1596943A CN A2004100245359 A CNA2004100245359 A CN A2004100245359A CN 200410024535 A CN200410024535 A CN 200410024535A CN 1596943 A CN1596943 A CN 1596943A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- capsule
- eupolyphaga
- tabanus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A leech capsule for treating blood stasis, hyspteromyoma, ovarian cyst, pelvic inflammation, etc is prepared from 9 Chinese-medicinal materials including leech, ground beetle, peach kernel, rhubarb, etc.
Description
Affiliated technical field
The present invention is a kind of Chinese medicinal capsule, particularly a kind of Chinese medicine composition that obvious conditioning and treating effect is arranged for multiple gynecologic chronic disease especially blood stasis disease.
Background technology
Women's disease is a lot, and various gynecologic chronic diseases have been brought great misery to the women, blood stasis disease especially, and the patient is very general, makes their daily life and work increase many difficulties.At present the Chinese medicine of the various gynecologic chronic diseases of treatment is a lot, and wherein mostly is to take Chinese herbal medicine, but not only bitter in the mouth tastes bad, and the time has been grown for the intestines and stomach certain stimulation and damaging action are arranged.
Summary of the invention
Technical assignment of the present invention is: provide that a kind of not only to treat blood stasis disease, treatment hysteromyoma, ovarian cyst, pelvic inflammatory disease (adnexitis) chronic diseases effect comparatively remarkable, and toxic and side effects is little, and the intestines and stomach is stimulated little Chinese medicinal capsule.
The present invention is a kind of Leech capsule, it is characterized in that: be equipped with in the capsule and comprise following mixture of ingredients powder (weight ratio): 1.0～3.5 parts of Hirudos (life), 0.1～0.9 part of Tabanus, 0.5～2.0 part of eupolyphaga (stir-fry), 3～20 parts in Semen Persicae, 5～25 parts of Caulis Sargentodoxaes, 2～15 parts of Radix Et Rhizoma Rhei (wine is processed), 10～20 parts of the Radixs Astragali, 10～40 parts of Radix Rehmanniae Preparata, 2～20 parts in Radix Glycyrrhizae.
Mix powder composition formula optimization scope in this Leech capsule, capsule is (weight ratio): 1.5～3 parts of Hirudos (life), 0.3～0.6 part of Tabanus, 1～1.5 part of eupolyphaga (stir-fry), 5～15 parts in Semen Persicae, 10～15 parts of Caulis Sargentodoxaes, 3～10 parts of Radix Et Rhizoma Rhei (wine is processed), 10～15 parts of the Radixs Astragali, 10～30 parts of Radix Rehmanniae Preparata, 3～15 parts in Radix Glycyrrhizae.
The best proportioning of mix powder composition is (weight ratio) in this Leech capsule, capsule: 2 parts of Hirudos (life), 0.4 part of Tabanus, 1.0 parts of eupolyphaga (stir-fry), 8 parts in Semen Persicae, 12 parts of Caulis Sargentodoxaes, 8 parts of Radix Et Rhizoma Rhei (wine is processed), 12 parts of the Radixs Astragali, 20 parts of Radix Rehmanniae Preparata, 10 parts in Radix Glycyrrhizae.
The monarch of this Leech capsule prescription, minister, help, make:
With Hirudo, Tabanus is monarch drug, and the two all can removing blood stasis, removing blood stasis, stimulate the menstrual flow, and the efficacy of a drug is high violent, and symptom that blood stasis disease causes, amenorrhea etc. can be eliminated; Eupolyphaga, Radix Et Rhizoma Rhei, Semen Persicae, Caulis Sargentodoxae are ministerial drug, mainly play reinforcement Hirudo removing blood stasis, removing blood stasis, stimulate the menstrual flow, can blood circulation promoting and blood stasis dispelling, and again can heat-clearing and toxic substances removing, promoting blood circulation and stopping pain; The Radix Astragali, Radix Rehmanniae Preparata are adjuvant drug, not only QI invigorating but also nourish blood, and to eliminate the untoward reaction that the monarch drug removing blood stasis is produced, QI invigorating can also make blood flow accelerate, and promote blood stasis to eliminate: Radix Glycyrrhizae is a messenger drug, and both QI invigorating, heat-clearing and toxic substances removing again can coordinating the actions of various ingredients in a prescription, eliminate untoward reaction.
All medicines share, and the result of its comprehensive function can more successfully treat blood stasis disease.Be noted that the dosage that to pay close attention to Hirudo, Tabanus and eupolyphaga, because certain toxicity is arranged.
Following table illustrated medicine monarch, minister, help, make the relation and alternative medicine:
| The medicine name | Function | The alternative medicine title | |
| Monarch | Hirudo | Removing blood stasis stimulates the menstrual flow | Rhizoma sparganic |
| Tabanus | Removing blood stasis stimulates the menstrual flow | Rhizoma Curcumae | |
| Minister | Eupolyphaga | Blood circulation and removing stasis | Radix Achyranthis Bidentatae |
| Radix Et Rhizoma Rhei | Blood circulation promoting and blood stasis dispelling | Do not have | |
| Semen Persicae | Blood circulation promoting and blood stasis dispelling | The Flos Carthami Radix Salviae Miltiorrhizae | |
| Caulis Sargentodoxae | The heat-clearing and toxic substances removing promoting blood circulation and stopping pain | Herba Houttuyniae | |
| Assistant | The Radix Astragali | QI invigorating | The Rhizoma Atractylodis Macrocephalae |
| Radix Rehmanniae Preparata | Nourish blood | Radix Angelicae Sinensis | |
| Make | Radix Glycyrrhizae | Coordinating the actions of various ingredients in a prescription | Do not have |
Why this Leech capsule adopts the encapsulated form of medicated powder, and do not take forms such as other dosage forms such as tablet, powder, pill, its final purpose is exactly in order to guarantee giving full play to of pharmaceutical efficacy, to use other dosage form, the efficacy of a drug is is easily scattered and disappeared, and just is difficult to play the effect of expection.And this dosage form of the present invention had both made medicine can fully act on human body, because capsular protection has been arranged, was unlikely to the intestines and stomach of human body is caused damage again, thereby reached the optimum efficiency that prescription is cured the disease.Utilize prescription of the present invention take other dosage forms be not cannot, but the medicament of every other form is all capsular remarkably productive not as the present invention.
Because the comprehensive function of used Chinese medicine, the present invention has removing blood stasis, removing blood stasis, and eliminating stagnation is stimulated the menstrual flow, the analgesic effect, uses capsule of the present invention, and hysteromyoma tumor body is dwindled, and menstruation transfers to normally, and various malaise symptoms alleviate even disappear simultaneously.Through using proof, Leech capsule has positive effect to the blood stasis disease, and effective percentage is more than 95%.This medicinal method: oral in the clean back of menstruation, one day 3 gram divides clothes 2-3 time, and serveing on one month is a course of treatment.Menstrual period, age of sucking, pregnancy period, menorrhagia overfrequency, blood deficiency person can not use medicine of the present invention, the period in a medicine maror of avoiding eating anything raw or cold.
The specific embodiment
Embodiment 1:
With 3.5 parts of Hirudos (life), 0.9 part of Tabanus, 2.0 parts of eupolyphaga (stir-fry), 20 parts in Semen Persicae, 25 parts of Caulis Sargentodoxaes, 15 parts of Radix Et Rhizoma Rhei (wine is processed), 20 parts of the Radixs Astragali, 40 parts of Radix Rehmanniae Preparata, 20 parts in Radix Glycyrrhizae, pulverize separately becomes the end, through the high-temperature sterilization sterilization treatment, incapsulate, clean medicine weighs 0.5 gram in every capsules.
All the other embodiment manufacture methods are the same, and difference just prescription is different, and prescription is as following table.The numerical value of each composition is the gravimetric value of unit unanimity among each embodiment.
The Example formulations table
| Composition | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 | Embodiment 7 | Embodiment 8 | Embodiment 9 | Embodiment 10 | Embodiment 11 | Embodiment 12 | Embodiment 13 | Embodiment 14 | Embodiment 15 |
| Hirudo | ??1 | ??2 | 3 | ??1.5 | ?2.5 | ?3.5 | 2.2 | 1.8 | 2 | 3 | 1.5 | 1.6 | 1.9 | 2 |
| Tabanus | ??0.1 | ??0.2 | 0.3 | ??0.4 | ?0.5 | ?0.6 | 0.7 | 0.9 | 0.3 | 0.8 | 0.5 | 0.4 | 0.5 | 0.4 |
| Eupolyphaga | ??0.5 | ??0.6 | 1.7 | ??0.8 | ?1.9 | ?1.0 | 1.5 | 1.2 | 1.3 | 1.4 | 1.5 | 1.1 | 2.0 | 1 |
| Semen Persicae | ??3 | ??5 | 8 | ??10 | ??11 | ?12 | 13 | 3 | 18 | 20 | 15 | 17 | 9 | 8 |
| Caulis Sargentodoxae | ??5 | ??8 | 10 | ??15 | ??17 | ?20 | 22 | 25 | 18 | 13 | 6 | 11 | 24 | 12 |
| Radix Et Rhizoma Rhei | ??2 | ??3 | 5 | ??7 | ??9 | ?11 | 14 | 15 | 12 | 10 | 7 | 4 | 6 | 8 |
| The Radix Astragali | ??10 | ??12 | 14 | ??15 | ??18 | ?16 | 20 | 13 | 11 | 17 | 10 | 15 | 19 | 12 |
| Radix Rehmanniae Preparata | ??10 | ??15 | 20 | ??25 | ??30 | ?35 | 40 | 13 | 18 | 33 | 28 | 36 | 24 | 20 |
| Radix Glycyrrhizae | ??2 | ??5 | 8 | ??12 | ??15 | ?18 | 20 | 7 | 4 | 16 | 17 | 12 | 14 | 10 |
Grope through practice, optimum ratio scope of the present invention is (weight ratio): 1.5～3 parts of Hirudos (life), 0.3～0.6 part of Tabanus, 1～1.5 part of eupolyphaga (stir-fry), 5～15 parts in Semen Persicae, 10～15 parts of Caulis Sargentodoxaes, 3～10 parts of Radix Et Rhizoma Rhei (wine is processed), 10～15 parts of the Radixs Astragali, 10～30 parts of Radix Rehmanniae Preparata, 3～15 parts in Radix Glycyrrhizae.
The prescription preferred range is (weight ratio): 2～3 parts of Hirudos (life), 0.4～0.6 part of Tabanus, 1.2～1.5 parts of eupolyphaga (stir-fry), 8～10 parts in Semen Persicae, 12～15 parts of Caulis Sargentodoxaes, 8～10 parts of Radix Et Rhizoma Rhei (wine is processed), 11～13 parts of the Radixs Astragali, 18～23 parts of Radix Rehmanniae Preparata, 8～12 parts in Radix Glycyrrhizae.
Best proportioning is (weight ratio): 2 parts of Hirudos (life), 0.4 part of Tabanus, 1.0 parts of eupolyphaga (stir-fry), 8 parts in Semen Persicae, 12 parts of Caulis Sargentodoxaes, 8 parts of Radix Et Rhizoma Rhei (wine is processed), 12 parts of the Radixs Astragali, 20 parts of Radix Rehmanniae Preparata, 10 parts in Radix Glycyrrhizae.
Capsule of the present invention at the patient mainly be diagnosed as and suffer from hysteromyoma, ovarian cyst, stagnant amenorrhea, the pelvic inflammatory disease (adnexitis) of the blood stasis of blood through gynaecopathia generaI investigation, B ultrasonic, show as hypomenorrhea, darkish complexion, clot arranged, dysmenorrhea etc.Owing to take the other drug DeGrain for a long time, person's 156 examples of taking this capsule for treating voluntarily, wherein:
Hysteromyoma: 116 examples account for 74.4%; Age 35-56 year, 1.6～7 centimetres of tumor body sizes;
Ovarian cyst: 48 examples account for 30.8%; Age 29-54 year, 4.0～6.3 centimetres of cyst sizes;
Merge pelvic inflammatory disease: 57 examples account for 36.5%;
Hypomenorrhea, darkish complexion, premenstrual abdominal pain: 38 examples account for 24.4%.
Therapeutic outcome:
The patient serve on Leech capsule B ultrasonic check after one course of treatment:
In hysteromyoma 116 examples, 110 routine effects are obvious, and the tumor body has dwindling in various degree, and scope 0.3-2.1 centimetre is not waited, and 6 routine tumor bodies do not have obvious change; Obvious effective rate 94.8%;
In ovarian cyst 48 examples, 45 routine effects are obvious, and cyst has dwindling in various degree, and scope 2-5.2 centimetre is not waited, and 14 routine cysts disappear obvious effective rate 93.8%, cure rate 29.2%; After 31 routine produce effects ovarian cyst patients obeyed second course of treatment Leech capsule again, wherein 27 routine cysts disappeared, and cyst disappears total cure rate 93.8% behind the 4 remaining example clothes medicines the 3rd course of treatment.
Merge in pelvic inflammatory disease 57 examples, the obvious effective rate of taking medicine is that lower abdomen weighs down pain alleviating in various degree all arranged after 100%, one course of treatment;
38 examples of hypomenorrhea, darkish complexion, the premenstrual abdominal pain obvious effective rate of taking medicine is 100%, the menstruation that can both come in time after the medication, and more through measuring, color and luster is red, and stomachache alleviates or disappears substantially; 12 routine menoxenias companion distending pain of the breast persons (the 3-5 month rises once) wherein, menstrual onset after one course of treatment of medication, distending pain of the breast disappears.
It is as follows now to lift several cases:
Example 1, Song Cuiying, 47 years old, Licheng City, Jinan Sha Sancun people, the 2003.10.14 B ultrasonic of having a medical check-up was diagnosed as 5.7 centimetres of right ovary cysts, took medicine a course of treatment, and 3.4 centimetres of B ultrasonic check cysts are checked cyst second course of treatment of taking medicine and are disappeared.
Example 2, Chen Jing, 38 years old, Zhang Matun people from village, Licheng City, Jinan, the B ultrasonic of having a medical check-up is diagnosed as 5.2 centimetres of right ovary cysts, takes medicine a course of treatment, and B ultrasonic check cyst disappears.
Example 3, Chou Junhua, 28 years old, Licheng City, Jinan Liang Ercun people, having a medical check-up is diagnosed as 4.8 centimetres of merging of right ovary cyst adnexitis, takes medicine two courses of treatment, and B ultrasonic check cyst disappears; Gynecological looks into the bilateral adnexa not to be had tenderness and increases slightly and thicken, normal.
Example 4, Wang Mei, 36 years old, Licheng City, Jinan Da Xincun people, the B ultrasonic of having a medical check-up is diagnosed as 2 centimetres of anterior uterine wall muscular tumors, takes medicine a course of treatment, and B ultrasonic check muscular tumor disappears;
Example 5, Yang Xinghui, 29 years old, Zhang Matun people from village, Licheng City, Jinan, the B ultrasonic of having a medical check-up is diagnosed as 4.2 centimetres of left ovary cysts, takes medicine a course of treatment, and B ultrasonic check cyst disappears.
Example 6, Xue Liancui, 42 years old, Xiao Sujia people from village, Licheng City, Jinan, amount is few during menstrual onset, and darkish complexion has the blood stasis piece, stomachache, general malaise, agitation, continue menorrhagia stomachache and simultaneous phenomenon disappearance after 4,5 days, year medical history surplus having ten like this, the ametria oophoropathy of having a medical check-up is taken medicine three courses of treatment, amount is many during menstrual onset, does not have stomachache and uncomfortable; Follow up a case by regular visits to half a year, menstruation is normal always, comes the time of tide suitable invariably.
Claims (3)
1, a kind of Leech capsule is characterized in that: be equipped with in the capsule and comprise following mixture of ingredients powder (weight ratio): 1.0～3.5 parts of Hirudos (life), 0.1～0.9 part of Tabanus, 0.5～2.0 part of eupolyphaga (stir-fry), 3～20 parts in Semen Persicae, 5～25 parts of Caulis Sargentodoxaes, 2～15 parts of Radix Et Rhizoma Rhei (wine is processed), 10～20 parts of the Radixs Astragali, 10～40 parts of Radix Rehmanniae Preparata, 2～20 parts in Radix Glycyrrhizae.
2, Leech capsule according to claim 1 is characterized in that: the mix powder composition formula optimization scope in the capsule is (weight ratio): 1.5～3 parts of Hirudos (life), 0.3～0.6 part of Tabanus, 1～1.5 part of eupolyphaga (stir-fry), 5～15 parts in Semen Persicae, 10～15 parts of Caulis Sargentodoxaes, 3～10 parts of Radix Et Rhizoma Rhei (wine is processed), 10～15 parts of the Radixs Astragali, 10～30 parts of Radix Rehmanniae Preparata, 3～15 parts in Radix Glycyrrhizae.
3, Leech capsule according to claim 1 and 2 is characterized in that: the best proportioning of the mix powder composition in the capsule is (weight ratio): 2 parts of Hirudos (life), 0.4 part of Tabanus, 1.0 parts of eupolyphaga (stir-fry), 8 parts in Semen Persicae, 12 parts of Caulis Sargentodoxaes, 8 parts of Radix Et Rhizoma Rhei (wine is processed), 12 parts of the Radixs Astragali, 20 parts of Radix Rehmanniae Preparata, 10 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100245359A CN1265818C (en) | 2004-08-04 | 2004-08-04 | Leech capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100245359A CN1265818C (en) | 2004-08-04 | 2004-08-04 | Leech capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1596943A true CN1596943A (en) | 2005-03-23 |
| CN1265818C CN1265818C (en) | 2006-07-26 |
Family
ID=34663556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100245359A Expired - Fee Related CN1265818C (en) | 2004-08-04 | 2004-08-04 | Leech capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1265818C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1298364C (en) * | 2005-05-16 | 2007-02-07 | 徐究竟 | Medicine for treating pelvic inflammation and its preparing process |
| CN102225076A (en) * | 2011-06-14 | 2011-10-26 | 重庆时珍阁普生药业有限公司 | Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof |
| CN102657821A (en) * | 2012-05-28 | 2012-09-12 | 刘春义 | Drug for treating ovarian cyst |
| CN104069192A (en) * | 2013-03-26 | 2014-10-01 | 成都地奥集团天府药业股份有限公司 | A traditional Chinese medicine composition having anticancer effects and a preparing method and uses thereof |
-
2004
- 2004-08-04 CN CNB2004100245359A patent/CN1265818C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1298364C (en) * | 2005-05-16 | 2007-02-07 | 徐究竟 | Medicine for treating pelvic inflammation and its preparing process |
| CN102225076A (en) * | 2011-06-14 | 2011-10-26 | 重庆时珍阁普生药业有限公司 | Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof |
| CN102657821A (en) * | 2012-05-28 | 2012-09-12 | 刘春义 | Drug for treating ovarian cyst |
| CN104069192A (en) * | 2013-03-26 | 2014-10-01 | 成都地奥集团天府药业股份有限公司 | A traditional Chinese medicine composition having anticancer effects and a preparing method and uses thereof |
| CN104069192B (en) * | 2013-03-26 | 2017-04-12 | 成都地奥集团天府药业股份有限公司 | A traditional Chinese medicine composition having anticancer effects and a preparing method and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1265818C (en) | 2006-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
| CN101711851B (en) | Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof | |
| CN101757540A (en) | Traditional Chinese medicine composition for treating nephrotic syndrome and preparation method thereof | |
| CN100396315C (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN106729212B (en) | Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof | |
| CN100548354C (en) | A kind of oral liquid for the treatment of nephropathy | |
| CN102274417B (en) | Chinese prepared medicament for treating aplastic anemia | |
| CN1265818C (en) | Leech capsule | |
| CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
| CN1613481A (en) | Chinese patent drug for treating female ovarian cyst and its preparation | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN101711852A (en) | Traditional Chinese medicine composition for treating injury symptoms of liver cells and preparation method | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN102205096A (en) | Medicament for treating adnexitis and pelvic inflammation | |
| CN101757601B (en) | Traditional Chinese medicine composite for treating esophageal rheumatism and preparation method thereof | |
| CN102283993B (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN1931300A (en) | Externally applied medicine for treating women's dysmenorrhea | |
| CN100577199C (en) | Application of stomachic pill with cyperus and amomum | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN1480204A (en) | Preparation of Chinese herbal medicine for treating barrenness of women | |
| CN102988945B (en) | Traditional Chinese medicine prescription for treating enteritis | |
| CN100444877C (en) | A Chinese medicine for treating cholecystitis | |
| CN1223362C (en) | Chinese medicine composition for treating colitis | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060726 |